StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Zivo Bioscience's ebitda for the twelve months ending Jun 30, 2021 was -$8.95M. For fiscal 2021 it was -$8.65M. The highest annual figure on record is -$1.85M in fiscal 2011.

Annual ebitda

PeriodPeriod endValueChange
FY2021Dec 31, 2021-$8.65M–
FY2020Dec 31, 2020-$8.56M–
FY2019Dec 31, 2019-$8.35M–
FY2018Dec 31, 2018-$6.13M–
FY2017Dec 31, 2017-$6.31M–
FY2016Dec 31, 2016-$3.47M–
FY2015Dec 31, 2015-$3.03M–
FY2014Dec 31, 2014-$5.13M–
FY2013Dec 31, 2013-$3.09M–
FY2012Dec 31, 2012-$2.01M–
FY2011Dec 31, 2011-$1.85M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2021Jun 30, 2021-$1.75M–
Q1 FY2021Mar 31, 2021-$2.08M–
Q4 FY2020Dec 31, 2020-$1.76M–
Q3 FY2020Sep 30, 2020-$3.36M–
Q2 FY2020Jun 30, 2020-$1.03M–
Q1 FY2020Mar 31, 2020-$2.41M–
Q4 FY2019Dec 31, 2019-$3.77M–
Q3 FY2019Sep 30, 2019-$1.57M–
Q2 FY2019Jun 30, 2019-$2.04M–
Q1 FY2019Mar 31, 2019-$967.85K–
Q4 FY2018Dec 31, 2018-$1.62M–
Q3 FY2018Sep 30, 2018-$1.49M–
Q2 FY2018Jun 30, 2018-$1.34M–
Q1 FY2018Mar 31, 2018-$1.68M–
Q4 FY2017Dec 31, 2017-$2.60M–
Q3 FY2017Sep 30, 2017-$2.05M–
Q2 FY2017Jun 30, 2017-$875.20K–
Q1 FY2017Mar 31, 2017-$785.02K–
Q4 FY2016Dec 31, 2016-$636.41K–
Q3 FY2016Sep 30, 2016-$670.87K–
Q2 FY2016Jun 30, 2016-$1.52M–
Q1 FY2016Mar 31, 2016-$634.31K–
Q4 FY2015Dec 31, 2015-$657.50K–

More Zivo Bioscience figures

See a number that looks wrong?